1,2-dimethylhydrazine decreases expression ISO RGD:735253 6480464 1, 2-Dimethylhydrazine results in decreased expression of SCN5A mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:735253 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of SCN5A mRNA] CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:735253 6480464 Tetrachlorodibenzodioxin affects the expression of SCN5A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SCN5A mRNA CTD PMID:33387578 3,3',5,5'-tetrabromobisphenol A increases expression ISO RGD:735253 6480464 tetrabromobisphenol A results in increased expression of SCN5A mRNA CTD PMID:25172293 4,4'-sulfonyldiphenol increases expression ISO RGD:735253 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of SCN5A mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:735253 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of SCN5A gene CTD PMID:31683443 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SCN5A mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases methylation ISO RGD:735253 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of SCN5A exon CTD PMID:33297965 4,4'-sulfonyldiphenol decreases methylation ISO RGD:735253 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SCN5A promoter CTD PMID:33297965 4-amino-5-chloro-N-[1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl]-2-methoxybenzamide increases localization ISO RGD:731255 6480464 Cisapride results in increased localization of SCN5A protein mutant form CTD PMID:16301357 4-hydroxyphenyl retinamide decreases expression ISO RGD:735253 6480464 Fenretinide results in decreased expression of SCN5A mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO RGD:735253 6480464 Decitabine results in decreased methylation of SCN5A gene CTD PMID:27923600 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SCN5A mRNA CTD PMID:24780913 9-phenanthrol decreases activity ISO RGD:731255 6480464 9-phenanthrol results in decreased activity of SCN5A protein mutant form CTD PMID:30153324 Aflatoxin B2 alpha decreases methylation ISO RGD:731255 6480464 aflatoxin B2 results in decreased methylation of SCN5A intron CTD PMID:30157460 ajmaline decreases activity ISO RGD:735253 6480464 Ajmaline results in decreased activity of SCN5A protein CTD PMID:20174578 ajmaline affects response to substance ISO RGD:731255 6480464 SCN5A protein affects the susceptibility to Ajmaline CTD PMID:10662748 , PMID:15520322 all-trans-retinoic acid multiple interactions ISO RGD:731255 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3 more ... CTD PMID:23284745 amiodarone affects response to substance ISO RGD:731255 6480464 SCN5A polymorphism affects the susceptibility to Amiodarone CTD PMID:33824187 amiodarone decreases expression ISO RGD:735253 6480464 Amiodarone results in decreased expression of SCN5A mRNA CTD PMID:15520326 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SCN5A mRNA CTD PMID:16483693 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of SCN5A mRNA CTD PMID:36841081 benzo[a]pyrene affects methylation ISO RGD:731255 6480464 Benzo(a)pyrene affects the methylation of SCN5A 5' UTR CTD PMID:27901495 bisphenol A multiple interactions ISO RGD:731255 6480464 bisphenol A binds to and results in decreased activity of SCN5A protein CTD PMID:22848561 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SCN5A mRNA, [bisphenol A co-treated with tributyltin] results in increased expression of SCN5A mRNA CTD PMID:31129395 , PMID:36041667 bisphenol A decreases methylation ISO RGD:735253 6480464 bisphenol A results in decreased methylation of SCN5A promoter CTD PMID:27312807 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SCN5A gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SCN5A mRNA CTD PMID:25181051 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SCN5A mRNA CTD PMID:36041667 brompheniramine decreases activity ISO RGD:731255 6480464 Brompheniramine results in decreased activity of SCN5A protein CTD PMID:17010640 butanal decreases expression ISO RGD:731255 6480464 butyraldehyde results in decreased expression of SCN5A mRNA CTD PMID:26079696 cannabidiol decreases activity ISO RGD:731255 6480464 Cannabidiol results in decreased activity of SCN5A protein CTD PMID:30219789 chloroform decreases activity ISO RGD:731255 6480464 Chloroform results in decreased activity of SCN5A protein CTD PMID:22024336 choline multiple interactions ISO RGD:735253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCN5A gene CTD PMID:20938992 cisapride increases localization ISO RGD:731255 6480464 Cisapride results in increased localization of SCN5A protein mutant form CTD PMID:16301357 crizotinib decreases activity ISO RGD:731255 6480464 crizotinib results in decreased activity of SCN5A protein CTD PMID:23707608 crocidolite asbestos increases expression ISO RGD:735253 6480464 Asbestos, Crocidolite results in increased expression of SCN5A mRNA CTD PMID:29279043 Cuprizon affects expression EXP 6480464 Cuprizone affects the expression of SCN5A mRNA CTD PMID:27523638 daunorubicin decreases expression ISO RGD:731255 6480464 Daunorubicin results in decreased expression of SCN5A mRNA CTD PMID:26537877 , PMID:28940058 diclofenac decreases activity ISO RGD:731255 6480464 Diclofenac results in decreased activity of SCN5A protein CTD PMID:33617802 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SCN5A mRNA CTD PMID:19915844 doxorubicin affects methylation EXP 6480464 Doxorubicin affects the methylation of SCN5A gene CTD PMID:28962528 doxorubicin decreases expression ISO RGD:731255 6480464 Doxorubicin results in decreased expression of SCN5A mRNA CTD PMID:26537877 more ... endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SCN5A mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:735253 6480464 Ethanol results in increased expression of SCN5A mRNA CTD PMID:30319688 ethanol affects expression ISO RGD:735253 6480464 Ethanol affects the expression of SCN5A mRNA CTD PMID:30319688 ezogabine affects activity ISO RGD:731255 6480464 ezogabine affects the activity of SCN5A protein CTD PMID:28641963 flecainide affects response to substance ISO RGD:735253 6480464 SCN5A gene mutant form affects the susceptibility to Flecainide CTD PMID:17805561 flecainide affects response to substance ISO RGD:731255 6480464 SCN5A mutant form affects the susceptibility to Flecainide CTD PMID:12687841 fluorescein 5-isothiocyanate affects binding ISO RGD:731255 6480464 Fluorescein-5-isothiocyanate binds to SCN5A protein CTD PMID:27129696 fluvoxamine decreases activity ISO RGD:731255 6480464 Fluvoxamine results in decreased activity of SCN5A protein CTD PMID:19875396 fluvoxamine affects response to substance ISO RGD:731255 6480464 SCN5A protein affects the susceptibility to Fluvoxamine CTD PMID:19875396 folic acid multiple interactions ISO RGD:735253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCN5A gene more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:735253 6480464 Folic Acid results in decreased expression of SCN5A mRNA CTD PMID:25629700 furan increases expression EXP 6480464 furan results in increased expression of SCN5A mRNA CTD PMID:27387713 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SCN5A mRNA CTD PMID:33387578 ibogaine decreases activity ISO RGD:731255 6480464 Ibogaine results in decreased activity of SCN5A protein CTD PMID:23707769 icajine multiple interactions ISO RGD:731255 6480464 icajine binds to and results in decreased activity of SCN5A protein CTD PMID:21616062 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of SCN5A mRNA CTD PMID:17526999 L-methionine multiple interactions ISO RGD:735253 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of SCN5A gene CTD PMID:20938992 lidocaine affects response to substance ISO RGD:731255 6480464 SCN5A protein mutant form affects the susceptibility to Lidocaine CTD PMID:18599870 limonene multiple interactions ISO RGD:731255 6480464 limonene inhibits the reaction [2 more ... CTD PMID:29306026 lithium chloride decreases activity ISO RGD:731255 6480464 Lithium Chloride results in decreased activity of SCN5A protein CTD PMID:16144991 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SCN5A mRNA CTD PMID:28801915 meloxicam decreases activity ISO RGD:731255 6480464 Meloxicam results in decreased activity of SCN5A protein CTD PMID:33617802 methamphetamine decreases methylation ISO RGD:735253 6480464 Methamphetamine results in decreased methylation of SCN5A promoter CTD PMID:26307267 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of SCN5A mRNA CTD PMID:35863504 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of SCN5A gene CTD PMID:35440735 mexiletine affects binding ISO RGD:731255 6480464 Mexiletine binds to SCN5A protein CTD PMID:22848561 mitoxantrone decreases expression ISO RGD:731255 6480464 Mitoxantrone results in decreased expression of SCN5A mRNA CTD PMID:26537877 , PMID:28940058 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SCN5A gene CTD PMID:33148267 nefazodone affects activity ISO RGD:731255 6480464 nefazodone affects the activity of SCN5A protein CTD PMID:26821276 nifedipine decreases activity EXP 6480464 Nifedipine results in decreased activity of SCN5A protein CTD PMID:16331678 , PMID:17978865 nimesulide decreases activity ISO RGD:731255 6480464 nimesulide results in decreased activity of SCN5A protein CTD PMID:33617802 ozone multiple interactions ISO RGD:735253 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCN5A mRNA CTD PMID:27106289 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SCN5A mRNA CTD PMID:33387578 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SCN5A mRNA CTD PMID:32680482 pentanal increases expression ISO RGD:731255 6480464 pentanal results in increased expression of SCN5A mRNA CTD PMID:26079696 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of SCN5A gene CTD PMID:33148267 piroxicam decreases activity ISO RGD:731255 6480464 Piroxicam results in decreased activity of SCN5A protein CTD PMID:33617802 quercetin increases expression ISO RGD:731255 6480464 Quercetin results in increased expression of SCN5A protein CTD PMID:19207037 quinidine affects response to substance ISO RGD:735253 6480464 SCN5A gene mutant form affects the susceptibility to Quinidine CTD PMID:17805561 ranolazine multiple interactions ISO RGD:731255 6480464 Ranolazine inhibits the reaction [2 more ... CTD PMID:29306026 resveratrol multiple interactions ISO RGD:731255 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SCN5A mRNA CTD PMID:23557933 sodium arsenate increases expression ISO RGD:735253 6480464 sodium arsenate results in increased expression of SCN5A mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:731255 6480464 sodium arsenite results in decreased expression of SCN5A mRNA CTD PMID:21776218 sodium atom affects transport EXP 6480464 SCN5A protein affects the transport of Sodium CTD PMID:17065252 strychnine multiple interactions ISO RGD:731255 6480464 Strychnine binds to and results in decreased activity of SCN5A protein CTD PMID:21616062 sulforaphane increases expression ISO RGD:735253 6480464 sulforaphane results in increased expression of SCN5A mRNA CTD PMID:30529165 sunitinib decreases activity ISO RGD:731255 6480464 sunitinib results in decreased activity of SCN5A protein CTD PMID:21906609 , PMID:23707608 telmisartan increases activity ISO RGD:731255 6480464 telmisartan results in increased activity of SCN5A protein CTD PMID:29306026 tetrodotoxin decreases activity EXP 6480464 Tetrodotoxin results in decreased activity of SCN5A protein CTD PMID:17978865 titanium dioxide decreases expression ISO RGD:735253 6480464 titanium dioxide results in decreased expression of SCN5A mRNA CTD PMID:23557971 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of SCN5A mRNA CTD PMID:31129395 triptonide decreases expression ISO RGD:735253 6480464 triptonide results in decreased expression of SCN5A mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:731255 6480464 tris(2-butoxyethyl) phosphate affects the expression of SCN5A mRNA CTD PMID:29024780 valproic acid affects expression ISO RGD:731255 6480464 Valproic Acid affects the expression of SCN5A mRNA CTD PMID:25979313